ArticleCureus2025
A Proposal for Neurocognitive Assessment in Spanish-Speaking Adults With Phelan-McDermid Syndrome: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The main objective of this case report is to make a proposal for a specialized neurocognitive assessment battery designed to evaluate critical cognitive domains in Spanish-speaking adults with Phelan-McDermid syndrome (PMS). This battery includes measures for language processing, tactile perception, executive function, and adaptive behavior, providing a structured framework for assessing neurocognitive functioning in this population. PMS is a rare neurodevelopmental disorder caused by deletions or mutations in chromosome 22q13.33, leading to SHANK3 haploinsufficiency. This genetic alteration results in a range of clinical manifestations, including severe intellectual disability, profound language impairment, hypotonia, seizures, sensory abnormalities, and autistic traits. PMS presents significant challenges in neurocognitive assessment, particularly in Spanish-speaking adults, due to the absence of standardized diagnostic tools adapted to their needs. This case report describes a 29-year-old Spanish-speaking woman, genetically confirmed to have PMS due to a 22q13.33 deletion affecting 28 genes, including SHANK3. Her developmental history included early hypotonia, global developmental delays, limited language acquisition, and difficulties in adaptive behavior. A comprehensive neuropsychological evaluation was conducted using the Peabody Picture Vocabulary Test-III, Battelle Developmental Inventory, Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A), Adaptive Behavior Assessment System-II, Programa Integrado de Exploración Neuropsicológica Test Barcelona-2 (PIEN-2) subscales, and Ekman and Friesen Adapted Test. The results revealed severe impairments in expressive language, phonological discrimination, and tactile perception. The patient exhibited significant difficulties in recognizing emotions, particularly fear, sadness, and neutral expressions. Adaptive behavior assessments indicated profound deficits in conceptual, social, and practical domains, although executive functioning, as reported by caregivers, appeared preserved within a structured environment. This study highlights novel findings regarding phonological discrimination deficits and impaired facial emotion recognition in PMS, aspects that have been underexplored in previous research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.